A daily round up of CFDs and market news..

Riz

Experienced member
Messages
1,266
Likes
6
A daily round up of CFDs and market news provided by GNI Touch, a leading equity CFD supplier

Today's Company Announcements

GlaxoSmithKline is due to report Q1 PBT later today - consensus is for £1.3bn

Amvescap also are due to announce figures later today

Compaq announced Q1 EPS of 12c a share last night at the lower end of analysts expectations and announces that they see Q2 sales roughly flat with Q1 and is expanding its job cutting to 10% amid the slowing demand for PC's

Deutsche Telekom have reported a Q1 loss of 400m Euro's in line with market forecasts

Parthus Technologies Q1 total revenue up 58% to $9.8m

Fibernet Group H1 pre-tax profit up 118% to £3.2m with turnover up 35% to £24.6m

Laura Ashley 9 week LFL sales up 14% and final pre-tax profit of £10.2m compared to £4.1m loss last year

Wolverhampton & Dudley H1 pre-tax pre-exceptional profit up 36.4% to £30.7m and announce that talks with interested parties are to continue as two expressions of interest are incomplete

Markets and gossip

Ericsson and Sony are to have a briefing at 9:00 GMT on their mobile phone joint venture

US press reports that five major US banks would bid for Bridge if Reuters became the preferred bidder as they have been reported as saying they would prefer to see a third leading market data provider remain in the market than see the monopolistic situation a Reuters takeover would create

The Times reports on a board room split at EMI on the proposed merger with Bertelsmann

CMG continues to be affected by the market volatility but may be buoyed by the news that five executive and non-executive directors have increased their holding in the firm

BPT announce this morning that they have not received a counter-bid

The Guardian highlights that a lockin period for 11.1m shares in Baltimore, 2.2% of the total, expires on Wednesday

Yesterday's most active CFDs

ARM Holdings, Logica, Marconi, C&W, Invensys, BT, Diageo, Vodafone, Carlton Comms, GlaxoSmithKline

Riz
 
Top